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Synopsis



The thesis entitled “Towards The Total Synthesis of Phorboxazole A, Synthesis And Biological Evaluation of Coumarin Analogues As DNA Gyrase Inhibitors And Development of New Synthetic Methodologies” is divided into three chapters.
CHAPTER I: This chapter further divided into two sections.
SECTION A: This section describes biological importance of some antitumor    molecules     	and earlier synthetic approaches to C20-C32 fragment of the    	phorboxazoles.
SECTION B: This section comprises present work, the stereoconvergent synthesis of C20-C32 fragment of phorboxazoles.
Phorboxazole A and B (Scheme 1) rare marine macrolides isolated from the Indian ocean sponge Phorbas sp. by Searle and Molinski.1 Both C13 epimers comprised of a 21-membered macrolide ring that embodies three oxane rings, one oxazole and subtends a side chain that contains a second oxazole and a hemiketal oxane ring. These are among the most cytostatic natural products known, inhibiting the growth of tumor cells at nanomolar concentrations with mean GI50 = 1.58 x 10-9 M against NCI panel 60 tumor cell lines. These scarce natural products arrest cancer cell growth in S phase at low to subnanomolar concentrations, making them promising candidates for therapeutic development. The enormous biological activity and the fascinating molecule structure have stimulated synthetic efforts by a number of research groups and seven elegant total syntheses have been reported so far. The remarkable biological activities associated with the phorboxazoles make these compounds important leads for biotherapeutic development.2
We have depicted our strategy in the Scheme 1, which reveals the disconnection approach. The convergent synthesis of C20-C32 oxazole-oxane 1 achieved by coupling two subunits, pentasubstituted oxane 2 and oxazole sulfone 3 via modified Julia olefination. The oxane moiety 2 was synthesized from the bicyclic ketone 4.








Scheme 1
	The bycyclic alcohol 6 was prepared from the bycyclic ketone 4 in three step sequence using (-) Ipc2BH asymmetric hydroboration3 as a key step. It was converted to keto compound 7 by PCC oxidation in DCM in 85% yield (Scheme 2). Next task was to open the bicyclic ketone 7. It was thought that the best way of opening the bicyclic ketone was by making the corresponding ester 8 and hydrolyzing it. Thus a Baeyer – Villiger oxidation of the ketone 7 using m-CPBA and NaHCO3 in DCM yielded the ester 8 in 90% yield (Scheme 2). 

Scheme 2
Methanolysis of lactone 8 using catalytic amount of sulfuric acid in MeOH afforded the acetal ester 9 in 85% yield with a minor amount of the -isomer (at C-1 center). This ester consists of three stereocenters out of five in the central pyran moiety 1.  Next we turned our attention to obtain the stereocenters at C1 and C2 carbons of the pentasubstituted pyran ring 1. In that direction ester functionality of 9 was reduced with LAH in THF at ambient temparature to the corresponding alcohol 10 in 90% yield.  Then benzylation of the resulting primary alcohol with BnBr, NaH, and TBAI (catalytic) in THF furnished dibenzyl acetal 11 in 95% yield (Scheme 3).

Scheme 3
	Next the dibenzyl methyl acetal 11 was converted to lactol 12 under acidic conditions AcOH/H2O (2:1) at 55-60 oC for 12 h with 55% yield. Then the lactol 12 was oxidized to lactone 13 using PCC, CH3COONa, celite in CH2Cl2 for 3 h with 90% yield (Scheme 4).




Scheme 4
	Having made flat form to obtain the stereocenters at C1 and C2 of pentasubstituted pyran moiety 1, we thought to epimerize the α-methyl at C2 of the lactone 13. For this purpose we made experiments using MeONa/MeOH and refluxing KOH/EtOH which were resulted in ring opening of the lactone to corresponding hydroxy ester and hydroxy acid respectively. And acid catalyzed cyclization of hydroxy acid resulted  in epimerized lactone 14, and base catalyzed cyclization of hydroxy ester also led to the same 14. To avoid ring opening of lactone it was thought that to use mild base such as DBU. Epimerization was successfully carried out with DBU in THF for 12 h with 85% yield with 100% conversion (Scheme 5).4 Epimerization was confirmed by 1H NMR and NOE studies.

Scheme 5
	Accordingly, nucleophilic addition of lithiumtrimethylsilyl acetylide which was generated in situ from acetylenetrimethylsilane and n-BuLi at -78 oC to the resulting epi-lactone 14 at -78 oC in THF provided inseparable anomeric mixture of hemiketals 15 in 90% yield. Reduction of hemiketal to pyran 16 was carried out with excess Et3SiH/BF3.Et2O in CH2Cl2/CH3CN (1:1) at -40 oC.5 The reaction was proceeded to completion within 1 h, furnishing exclusively pentasubstituted pyarn moiety 16 in which ether linkage between C1 and C5 is in syn configuration (Scheme 6). The stereochemistry of 16 was confirmed by 1H NMR and NOE experiments.

Scheme 6
	Desilylation and hydrolysis of the triple bond via oxymercuration in Markownikoff’s fashion was effected in a single transformation using yellow HgO and aq.H2SO4 in refluxing acetone for 2 h with 70% yield to give keto oxane 2 (Scheme 6).6

Scheme 7
	Many attempts went in vain to make the desired oxazole 5. Finally we followed the Conforth’s synthesis of oxazoline 19, which was prepared by employing ethyl acetimidate hydrochloride 17 and DL-serine methyl ester hydrochloride 18 in CH2Cl2 in presence of Et3N for 12 h. The resulting oxazoline 19 was oxidized to oxazole 5 by using CuBr2, HMTA and DBU in CH2Cl2 for 2 h at ambient temparature in 75% yield. Further the ester functionality in oxazole was reduced to alcohol 20 by employing DIBAL-H.7 Then the alcohol was made into thioether 21 under Mitsnobu reaction conditions using mercaptobenzothiazole, DEAD and TPP in THF for 4 h. Thioether was oxidized to oxazole sulfone 3 by oxone in THF:H2O:MeOH (2:1:1) for 12 h in 90 % yield (Scheme 7).
Scheme 8
Coupling of oxazole sulfone and the ketone under the modified Julia olefination reaction conditions gave the C20-C32 fragment as separable E:Z isomers in a ratio of 9:1 in 50% yield (40% conversion) based on recovered starting material (Scheme 8).
	In conclusion, the practical synthesis of the penta substituted pyran C20-C32 fragment achieved from bycyclic ketone is described. Modified Julia olefination reaction between sulfone and the ketone was also achieved. 

CHAPTER II : This chapter again divided into two sections.
SECTION A: This section deals with introduction to coumarin and quinolone antibiotics and dual action drugs.
SECTION B: This section deals with the present work, synthesis and biological                                              		    evaluation of coumarin linked fluoroquinolones, phthalimides and naph-		                thalimides as potential DNA gyrase Inhibitors. 
	Over the past decade, bacterial DNA gyrase has drawn much attention as a selected target for finding potent antibacterial agents. Accordingly, a number of synthetic quinoline antibacterial agents have been developed and are now widely used for treatment of bacterial infectious diseases. Quinolones inhibit DNA gyrase and topoisomerase  IV, and  cause  bacterial cell death. Besides the quinolones, naturally occurring antibacterial agents, such as novobiocin  (NB; Fig. 1) have also been identified as bacterial DNA gyrase inhibitors.8  Novobiocin  inhibits ATPase activity of DNA gyrase by competing  with ATP for binding to the gyrase subunit B. Based on this background it was considered of interest to prepare new type of dual-acting coumarin-linked hybrids possessing phthalimide, naphthalimide and quinolone moieties to unravel their antibacterial activity and DNA gyrase inhibition potential.
	A hybrid molecule synthesis strategy was employed to develop new molecules with potential antibacterial activity. Three types of coumarin-linked hybrids have been synthesized. The coumarin ring system has been linked to phthalimido, naphthalimido and quinolone moieties at 4-position through piperazino alkane spacers. These compounds have been evaluated for their antibacterial activity. Some of these new hybrids particularly phthalimido and naphthalimido ones have exhibited DNA gyrase inhibition activity.

Figure. 1
Chemistry
	The coumarin precursors 4-(1-piperazinyl)-2H-1-benzopyran-2-one 25a and 25b were synthesized9 from the starting materials o-hydroxy acetophenones 23a, 23b in two step sequence. Compounds 23a, 23b were treated with diethylcarbonate in the presence of Na to reflux for 4 h to obtain  substituted 4-hydroxy coumarins 24a, 24b which 
inturn heated with piperazine at 160 oC for 1h to obtain the precursors 25a and 25b (Scheme11). 
Scheme 9

	 Quinolone precursors were obtained from substited anilines 26a and 26b by reacting with diethylethoxymethylenemalonate at 110 oC for 1.5 h to give 2-(3,4-dihaloanilino-methylene)melonates 27a, 27b which upon heating with diphenylether at 250 oC for 1h furnished  28a, 28b (Scheme 10).

Scheme 10
	N-alkylbromoquinolones 32a-g were synthesized by reacting 28a, 28b with dibromoalkanes 29a-d in acetone in the presence of potassium carbonate. The precursors N-alkylbromophthalimides 33a,b and N-alkylbromonaphthalimides 34a,b were prepared by reacting phthalimide 30 and naphthalimide 31 with corresponding dibromoalkanes 29a-d (Scheme 11).

Scheme 11

	The new cross linked hybrids of coumarins with quinolones, phthalimides and naphthalimides have been synthesized by coupling 4-(1-piperazinyl) coumarin 25a or 25b with N-alkylbromo-6,7-dihaloquinolones 32a-g, N-alkylbromophthalimide 33a,b and N-alkylbromonaphthalimides 34a,b respectively. The reaction was carried out in the presence of anhydrous K2CO3 at reflux in acetonitrile for 24 h to afford the coumarin-quinolone hybrids 35a-k, the coumarin-phthalimide analogues 36a-d and coumarin-naphthalimide analogues 37a-d (Scheme 12) in good yields. 







Scheme 12

Antibacterial activity
	The in-vitro antibacterial activity of the compounds was assessed along with ciprofloxacin by Kirby-Bauer method on both Gram negative and Gram-positive bacteria. The minimum inhibitory concentration of the compounds was determined by inoculating the test organisms (E. coli MTCC 443, B. subtilis MTCC 736) on Mueller-Hinton agar plates with different concentrations of compound (4 mg/mL, DMSO) followed by incubation at 37 oC for 16-18 hrs. To ensure that the solvent had no effect on bacterial growth, a control test with DMSO was also performed. Some of the compounds exhibited mild activity against E. coli. (Table1). However, these compounds were almost inactive against B. subtilis (MIC >60 g/mL). 

Inhibition of DNA supercoiling
	The ability of the coumarin linked hybrids to inhibit the supercoiling activity of DNA gyrase was tested. For this purpose very well studied E. coli DNA gyrase was employed. Ciprofloxacin was used as positive control in these assays as it has been shown to be a potent inhibitor of DNA supercoiling activity of the enzyme. Many of the compounds tested showed dose-dependent inhibition of enzyme activity. From the data (Table 1) it is clear that some of the compounds inhibit the DNA gyrase activity, particularly the phthalimido and naphthalimido linked coumarin hybrids (36a-d, 37a-d). One of the molecules from the quinolone linked coumarin series (35d) also exhibited promising DNA gyrase inhibition, which could be considered as dual activity coumarin. Although compounds 36b,d and 37b-d  had good inhibitory activity against DNA gyrase, it did not show any antibacterial activity, presumably because of low permeability through bacterial membrane. Compounds 35d, 36a, 36c and 37a had potent DNA gyrase inhibitory activity and showed moderate antibacterial activity (Table 1). It is interesting to note that precursors 25a,b, 30 and 31 did not exhibit any significant inhibition of DNA-gyrase up to 50ug/mL. The precursors 28a,b could not be evaluated because of the insolubility in DMSO. Therefore, it appears that there is no intrinsic activity for the precursor fragment in these hybrid molecules.













Table 1. Minimal inhibitory concentrations (MIC) of coumarin hybrids against DNA gyrase and bacteria

Sl. No	Compound	R	X	Y	n	MIC against E. coli (g/mL)	MIC against DNA gyrase (g/mL)
  1	35a	CH3	F	Cl	2	>60	a
  2	35b	CH3	F	Cl	3	>60	a
  3	35c	CH3	F	Cl	4	>60	50
  4	35d	CH3	F	Cl	6	  53	30
  5	35e	C2H5	F	Cl	2	>60	a
  6	35f	C2H5	F	Cl	3	>60	50
  7	35g	CH3	F	F	2	>60	50
  8	35h	CH3	F	F	3	>60	a
  9	35i	CH3	F	F	4	>60	50
 10	35j	C2H5	F	F	2	>60	50
 11	35k	C2H5	F	F	3	>60	a
 12	36a	CH3	-	-	2	  35	30
 13	36b	CH3	-	-	3	>60	30
 14	36c	C2H5	-	-	2	  42	30
 15	36d	C2H5	-	-	3	>60	30
 16	37a	CH3	-	-	2	  40	30
 17	37b	CH3	-	-	3	>60	30
 18	37c	C2H5	-	-	2	>60	30
 19	37d	C2H5	-	-	3	>60	30
 	Ciprofloxacin					            5	10

aNo inhibition was observed.

Conclusion
	The present studies demonstrate the synthesis of these hybrid molecules and evaluate their antibacterial activity as well as their ability to inhibit DNA gyrase. These new coumarin based hybrids exhibit moderate antibacterial activity against E. coli. with promising DNA gyrase inhibition activity and as such warrant further investigation by modulation of linker spacers and functional groups in the coumarin ring system. It is anticipated that this structure activity based approach could lead to the development of much improved inhibitors of DNA gyrase with better in-vivo efficacy. 



CHAPTER III: This chapter describes new methodologies for the synthesis of 2-				    deoxyglycosides and 2,3-unsaturated glycosides. This chapter again 			    divided into two sections.
SECTION A: This section describes the synthesis of 2-deoxyglycosides from D-glycals using CeCl3.7H2O-NaI as a novel reagent.

	Deoxyglycosides are well-known structural components of several biologically active compounds, especially antitumor antibiotics such as anthracyclines, aureolic acids, orthosamycins, angucyclins, and enediynes. In particular, 2-deoxy-α-glycosides are present in many bioactive natural products including compactin, olivomycin, mithramycin, daunomycin, calicheamicin and many others.10 In this context, several methods have been developed for the preparation of 2-deoxy sugars in a multi-step sequence. Of these, the acid-catalyzed addition of an alcohol to acetylated glycals appears to be the most direct method for the synthesis of 2-deoxy pyranosides. However, only a few methods have been reported so far for the direct synthesis of 2-deoxy- α -glycosides from glycals. Thus the development of a neutral alternative such as the CeCl3.7H2O– NaI reagent system would extend the scope of this transformation. 


Scheme 13
	This is a mild and efficient method for the synthesis of 2-deoxyglycosides from glycals and alcohols using the CeCl3·7H2O–NaI reagent system. Thus, treatment of 3, 4, 6-tri-O-acetyl-D-glucal with alcohols in the presence of cerium(III) chloride heptahydrate–sodium iodide in acetonitrile afforded the corresponding 2-deoxyglycopyranosides in good yields with high α-selectivity (Scheme 13). The α -anomer was obtained exclusively, the structure of which was characterized by spectroscopic data (Table 2.). 



	However, in the absence of NaI, the glycals underwent Ferrier rearrangement under the influence of CeCl3·7H2O in refluxing acetonitrile to afford the corresponding 2,3-unsaturated hexopyranosides in good yields (Scheme 14). The products were obtained as a mixture of - α and β-anomers, favoring the α-anomer. The ratios of products were determined by the examination of the 1H NMR spectra of the crude products. 


Scheme 14

SECTION B: This section describes the synthesis of 2,3-unsaturated C and O and S-       			glycosides from D-glycals using phosphomolybdic acid supported on 			silica gel as an efficient catalyst.

	The acid-catalyzed allylic rearrangement of glycals in the presence of nucleophiles such as alcohols, thiols etc., and known as Ferrier rearrangement11 is widely employed to obtain 2, 3-unsaturated glycosides. Allyl C-glycosides are attractive synthons due to the presence of terminal double bond that is amenable to easy functionalization, for instance, by hydroxylation, hydrogenation, epoxidation and amino hydroxylation.  These glycosides or pseudoglycals represent versatile chiral intermediates towards the synthesis of modified carbohydrates and nucleosides with important pharmacological properties. This class of compounds can be transformed in to 2-deoxy or 2, 3-dideoxy sugars, which are building blocks for the total synthesis of many antibiotics.12 Due to its great significance in the area of carbohydrate chemistry, there has been a growing interest in the improvement of the Ferrier reaction by using a variety of catalysts.  
	Phosphomolybdic acid (PMA) belongs to the class of heteropoly acids (HPA). Catalysis using HPAs and related polyoxometalate compounds is a field of growing importance.13 HPAs are commercially cheap and environmentally friendly catalysts. They exhibit high activities and selectivities and allow cleaner processes over conventional catalysts. HPAs are promising solid acids, redox and bifunctional catalysts in homogeneous as well as in heterogeneous conditions. HPAs have a very strong, approaching the superacid region, Bronsted acidity greatly exceeding that of ordinary mineral acids and solid acid catalysts.  


Scheme 15
	In a typical experiment, a solution of triacetyl glucal and allyl trimethylsilane in acetonitrile was stirred with 1 mol% PMA-SiO2 at room temperature. The reaction was complete within 10 minutes to produce exclusively corresponding -4,6-di-O-acetyl-2,3-unsaturated C-allyl glycoside with high yield (Table 3., Scheme 15). After the reaction the catalyst was filtered and reused 5 times without any appreciable loss in catalytic activity and yields.


Scheme 16
	 2,3-unsaturated glycopyranosides were successfully prepared with nucleophiles such as alcohols and thiols. A mixture of two anomers of 2,3-unsaturated glycopyranosides ( and ) were obtained in the case of glucal and galactal when alcohol was the nucleophile, while exclusively -anomers were obtained with thiols (Table 3., Scheme 16). The predominant formation of this -anomer may arise from thermodynamic anomeric effect. 
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